BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23740922)

  • 1. A single dose of a DNA vaccine encoding apa coencapsulated with 6,6'-trehalose dimycolate in microspheres confers long-term protection against tuberculosis in Mycobacterium bovis BCG-primed mice.
    Carlétti D; Morais da Fonseca D; Gembre AF; Masson AP; Weijenborg Campos L; Leite LC; Rodrigues Pires A; Lannes-Vieira J; Lopes Silva C; Bonato VL; Horn C
    Clin Vaccine Immunol; 2013 Aug; 20(8):1162-9. PubMed ID: 23740922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice.
    Britton G; MacDonald DC; Brown JS; Collins MK; Goodman AL
    Immunology; 2015 Oct; 146(2):264-70. PubMed ID: 26095282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.
    Lu J; Wang C; Zhou Z; Zhang Y; Cao T; Shi C; Chen Z; Chen L; Cai C; Fan X
    Clin Dev Immunol; 2011; 2011():617892. PubMed ID: 21461375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model.
    Cervantes-Villagrana AR; Hernández-Pando R; Biragyn A; Castañeda-Delgado J; Bodogai M; Martínez-Fierro M; Sada E; Trujillo V; Enciso-Moreno A; Rivas-Santiago B
    Vaccine; 2013 Jan; 31(4):676-84. PubMed ID: 23196205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
    Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.
    Kolibab K; Yang A; Derrick SC; Waldmann TA; Perera LP; Morris SL
    Clin Vaccine Immunol; 2010 May; 17(5):793-801. PubMed ID: 20357059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
    Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z
    J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice.
    Wang C; Chen Z; Fu R; Zhang Y; Chen L; Huang L; Li J; Shi C; Fan X
    Med Microbiol Immunol; 2011 Aug; 200(3):165-75. PubMed ID: 21340709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Mycobacterium bovis BCG-naked DNA prime-boost vaccination strategy induced CD4⁺ and CD8⁺ T-cell response against Mycobacterium tuberculosis immunogens.
    Lu M; Xia ZY; Bao L
    J Immunol Res; 2014; 2014():395626. PubMed ID: 24741595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines.
    Hu Z; Jiang W; Gu L; Qiao D; Shu T; Lowrie DB; Lu SH; Fan XY
    J Mol Med (Berl); 2019 Dec; 97(12):1685-1694. PubMed ID: 31786669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous Boosting With
    Liu SJ; Tian SC; Zhang YW; Tang T; Zeng JM; Fan XY; Wang C
    Front Immunol; 2020; 11():2036. PubMed ID: 32983151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
    Muflihah H; Flórido M; Lin LCW; Xia Y; Triccas JA; Stambas J; Britton WJ
    Vaccine; 2018 Apr; 36(18):2462-2470. PubMed ID: 29602704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with DNA vaccines encoding MPB70 or MPB83 or a MPB70 DNA prime-protein boost does not protect cattle against bovine tuberculosis.
    Wedlock DN; Skinner MA; Parlane NA; Vordermeier HM; Hewinson RG; de Lisle GW; Buddle BM
    Tuberculosis (Edinb); 2003; 83(6):339-49. PubMed ID: 14623164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
    Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
    Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion.
    da Fonseca DM; Silva CL; Wowk PF; Paula MO; Ramos SG; Horn C; Marchal G; Bonato VL
    Infect Immun; 2009 Dec; 77(12):5311-21. PubMed ID: 19752029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.
    Santosuosso M; McCormick S; Zhang X; Zganiacz A; Xing Z
    Infect Immun; 2006 Aug; 74(8):4634-43. PubMed ID: 16861651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.
    Dey B; Jain R; Gupta UD; Katoch VM; Ramanathan VD; Tyagi AK
    PLoS One; 2011; 6(8):e23360. PubMed ID: 21858087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.
    Hu Z; Wong KW; Zhao HM; Wen HL; Ji P; Ma H; Wu K; Lu SH; Li F; Li ZM; Shu T; Xu JQ; Lowrie DB; Fan XY
    Mol Ther; 2017 May; 25(5):1222-1233. PubMed ID: 28342639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.